Pleural disorders encompass a variety of conditions affecting the thin membrane lining the lungs and chest cavity, leading to altered lung mechanics, impaired ventilation, and respiratory discomfort. Common pleural conditions include pleural effusion, pneumothorax, pleuritis, and pleural fibrosis, each with unique mechanisms and clinical implications. These disorders can result from infections, malignancies, trauma, autoimmune diseases, or chronic systemic illnesses, and they often present with chest pain, shortness of breath, and diminished breath sounds on physical examination. Diagnosis of pleural disorders integrates clinical evaluation with imaging and laboratory investigations. Chest X-rays, ultrasound, and computed tomography provide insight into fluid accumulation, air leaks, or thickening of the pleural layers. Analysis of pleural fluid obtained via thoracentesis can differentiate transudative from exudative effusions, guiding targeted treatment. In selected cases, pleural biopsy or thoracoscopy may be necessary for definitive diagnosis, especially in suspected malignancy or chronic inflammatory conditions.
Management strategies are tailored to the underlying cause and the severity of symptoms. Therapeutic approaches include pleural fluid drainage, chest tube placement, antibiotics for infections, anti-inflammatory agents, and, in chronic or recurrent cases, pleurodesis or surgical intervention. Supportive care, including oxygen supplementation and pain management, is often necessary to maintain respiratory function. Recent advances in minimally invasive techniques, imaging guidance, and targeted therapies have enhanced the safety and effectiveness of interventions. By integrating accurate diagnosis, individualized therapy, and supportive care, the management of pleural disorders aims to restore lung function, relieve symptoms, and address the underlying pathology.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation